175 related articles for article (PubMed ID: 33537238)
1. Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis.
Lee JB; Kim HS; Ham A; Chang JS; Shin SJ; Beom SH; Koom WS; Kim T; Han YD; Han DH; Hur H; Min BS; Lee KY; Kim NK; Park YR; Lim JS; Ahn JB
Front Oncol; 2020; 10():609313. PubMed ID: 33537238
[TBL] [Abstract][Full Text] [Related]
2. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
3. Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score Analysis.
Shin YS; Yu CS; Park JH; Kim JC; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Joo JH; Kim JH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):136-144. PubMed ID: 28816139
[TBL] [Abstract][Full Text] [Related]
4. Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis.
Shin YS; Park JH; Yoon SM; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Choi EK; Ahn SD; Lee SW; Kim JH
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):630-639. PubMed ID: 29678529
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of preoperative chemotherapy with concurrent chemoradiotherapy combined with TME for 305 patients with locally advanced rectal cancer].
Muyasha A; Liu WY; Jin J; Li S; Tang Y; Li N; Ren H; Fang H; Lu NN; Tang Y; Chen B; Wang SL; Song YW; Liu YP; Qi SN; Li YX
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1122-1131. PubMed ID: 34695905
[No Abstract] [Full Text] [Related]
6. Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis.
Kim Y; Kim DY; Kim TH; Kim SY; Baek JY; Kim MJ; Chang HJ; Cha Y; Park SC; Oh JH
Br J Radiol; 2018 Dec; 91(1092):20180143. PubMed ID: 30129789
[TBL] [Abstract][Full Text] [Related]
7. [Short-term efficacy of robotic-assisted total mesorectal excision with and without lateral lymph node dissection for mid-low advanced rectal cancer: a propensity score matching analysis].
Shi FY; Zhang L; Qin Q; Jin X; Hu CH; Yu TY; Ma L; Wang GH; Wu H; Xia P; Sun XJ; She JJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Apr; 23(4):370-376. PubMed ID: 32306605
[No Abstract] [Full Text] [Related]
8. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
[TBL] [Abstract][Full Text] [Related]
9. Preoperative chemoradiotherapy for clinically diagnosed T3N0 rectal cancer.
Park IJ; Kim JY; Yu CS; Lee JS; Lim SB; Lee JL; Yoon YS; Kim CW; Kim JC
Surg Today; 2016 Jan; 46(1):90-96. PubMed ID: 25712223
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of surgery alone versus surgery following preoperative chemoradiotherapy for early T3 rectal cancer: A propensity score analysis.
Cho SH; Choi GS; Kim GC; Seo AN; Kim HJ; Kim WH; Shin KM; Lee SM; Ryeom H; Kim SH
Medicine (Baltimore); 2017 Mar; 96(12):e6362. PubMed ID: 28328820
[TBL] [Abstract][Full Text] [Related]
11. Impact of neoadjuvant chemoradiotherapy on the local recurrence and distant metastasis pattern of locally advanced rectal cancer: a propensity score-matched analysis.
Yu L; Xu TL; Zhang L; Shen SH; Zhu YL; Fang H; Zhang HZ
Chin Med J (Engl); 2021 Sep; 134(18):2196-2204. PubMed ID: 34553701
[TBL] [Abstract][Full Text] [Related]
12. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
[TBL] [Abstract][Full Text] [Related]
13. Continuous Effect of Radial Resection Margin on Recurrence and Survival in Rectal Cancer Patients Who Receive Preoperative Chemoradiation and Curative Surgery: A Multicenter Retrospective Analysis.
Sung S; Kim SH; Lee JH; Nam TK; Jeong S; Jang HS; Song JH; Lee JW; Bae JM; Lee JH
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):647-653. PubMed ID: 28581407
[TBL] [Abstract][Full Text] [Related]
14. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
Lin Y; Lin H; Xu Z; Zhou S; Chi P
J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
[No Abstract] [Full Text] [Related]
15. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
[No Abstract] [Full Text] [Related]
16. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
[TBL] [Abstract][Full Text] [Related]
18. What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy?
Trakarnsanga A; Gonen M; Shia J; Goodman KA; Nash GM; Temple LK; Guillem JG; Paty PB; Garcia-Aguilar J; Weiser MR
Ann Surg Oncol; 2013 Apr; 20(4):1179-84. PubMed ID: 23328971
[TBL] [Abstract][Full Text] [Related]
19. Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.
He F; Chen M; Xiao WW; Zhang Q; Liu Y; Zheng J; Wan XB; Gao YH
Jpn J Clin Oncol; 2021 Aug; 51(9):1391-1399. PubMed ID: 34155513
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of controversial issues in the treatment of cT3N0-2 rectal cancer: a 10-year cohort analysis using propensity-score matching.
Kim JC; Yu CS; Lim SB; Park IJ; Yoon YS; Kim CW; Kim JH; Kim TW
Int J Colorectal Dis; 2021 Dec; 36(12):2649-2659. PubMed ID: 34398263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]